Lars Rebien Sørensen
Chair of the Board of Directors, Novo Nordisk · since 2025
Former President and CEO of Novo Nordisk (2000–2016); chair of Novo Holdings from 2018 to 2025. Elected chair at an extraordinary general meeting in November 2025 and re-elected at the 2026 annual general meeting.
In the news
Novo Nordisk AGM re-elects Lars Rebien Sørensen as chair
At the annual general meeting on 26 March 2026, shareholders re-elected Lars Rebien Sørensen as board chair and Cees de Jong as vice chair.
Management